A new visual rating scale for Ioflupane imaging in Lewy body disease

A new visual rating scale for Ioflupane imaging in Lewy body disease

Background: Dopaminergic loss on 123I-Ioflupane brain imaging is a recognised biomarker for dementia with Lewy bodies. It is usually assessed using a visual rating scale developed for Parkinson's disease, which may not be optimal for dementia with Lewy bodies, as patterns of dopaminergic loss c...

Full description

Bibliographic Details
Main Authors: Jim J. Lloyd, George Petrides, Paul C. Donaghy, Sean J. Colloby, Johannes Attems, John T. O'Brien, Gemma Roberts, Alan J. Thomas
Format: Article
Language:English
Published: Elsevier 2018-01-01
Series:NeuroImage: Clinical
Online Access:http://www.sciencedirect.com/science/article/pii/S2213158218302870

Internet

http://www.sciencedirect.com/science/article/pii/S2213158218302870

Similar Items